# Efficacy and Safety Assessment of IRE of Localized Prostate Cancer

> **NCT04192890** · NA · UNKNOWN · sponsor: **I.M. Sechenov First Moscow State Medical University** · enrollment: 12 (estimated)

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma

## Interventions

- **DEVICE:** Focal irreversible electroporation of the prostate cancer

## Key facts

- **NCT ID:** NCT04192890
- **Lead sponsor:** I.M. Sechenov First Moscow State Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-27
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2021-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04192890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04192890, "Efficacy and Safety Assessment of IRE of Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04192890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*